Stk24 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
STK24 (Serine/Threonine Kinase 24), also known as MST3 (Mammalian Ste20-like Kinase 3), is a member of the Ste20 family of serine/threonine kinases. Located on chromosome 13q12.11, STK24 encodes a 462-amino acid protein that plays critical roles in stress-activated signaling, apoptosis regulation, and neuronal function. The protein is highly expressed in the brain and has been increasingly recognized for its involvement in neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD) [1][2].
¶ Gene and Protein Structure
The STK24 gene spans approximately 45 kb and consists of 12 exons. The encoded MST3 protein contains several critical structural domains:
- N-terminal Kinase Domain: Catalytic domain responsible for ATP binding and phosphoryl transfer (residues 1-280)
- Coiled-coil Region: Mediates protein-protein interactions and dimerization (residues 281-350)
- C-terminal Regulatory Domain: Contains autophosphorylation sites that regulate kinase activity (residues 351-462)
MST3 exists in both cytosolic and membrane-associated forms. The kinase is activated by autophosphorylation at Thr190 (analogous to Thr183 in MST1/2) within the activation loop, which is critical for its catalytic activity [3].
STK24/MST3 is a key component of the mitogen-activated protein kinase (MAPK) cascade. It functions upstream of MKK4 and MKK7, which then activate JNK (c-Jun N-terminal kinase) and p38 MAPK pathways. This cascade is activated by cellular stresses including oxidative stress, cytokine signaling, and excitotoxicity [4].
STK24 interacts with the hippo signaling pathway, a fundamental regulator of cell growth, apoptosis, and tissue homeostasis. MST3 can phosphorylate and regulate LATS1/2 kinases, which in turn control the activity of YAP/TAZ transcriptional co-activators. Dysregulation of hippo signaling has been implicated in neurodegeneration [5].
In neurons, STK24 plays several critical roles:
- Synaptic Plasticity: Regulates dendritic spine morphology and synaptic strength through modulation of actin cytoskeleton dynamics [6]
- Axon Guidance: Controls growth cone collapse and axon pathfinding through semaphorin signaling
- Autophagy Regulation: Phosphorylates key autophagy proteins including Beclin-1 and ATG14L, regulating autophagosome formation
- Mitochondrial Dynamics: Influences mitochondrial fission/fusion balance through interaction with Drp1
STK24 promotes apoptosis in response to cellular stress by:
- Activating JNK/p38 MAPK signaling
- Phosphorylating Bcl-2 family proteins
- Facilitating cytochrome c release from mitochondria
STK24 is ubiquitously expressed with highest levels in:
- Brain: Cerebral cortex, hippocampus, basal ganglia, brainstem
- Spinal Cord: Motor neurons, interneurons
- Peripheral Tissues: Heart, kidney, liver
Within the brain, STK24 is expressed in neurons, astrocytes, and microglia, with particular enrichment in synaptic compartments [7].
Multiple studies have implicated STK24 in AD pathogenesis:
- Tau Pathology: STK24 activity is elevated in AD brains and can phosphorylate tau protein at pathogenic sites, promoting NFT formation [8]
- Amyloid-β Toxicity: MST3 mediates amyloid-β-induced neuronal apoptosis through JNK activation
- Synaptic Loss: Dysregulated STK24 signaling contributes to synaptic dysfunction and spine loss in AD models
- Neuroinflammation: MST3 regulates microglial activation and pro-inflammatory cytokine production
STK24 connections to PD include:
- α-Synuclein Toxicity: MST3 is activated by α-synuclein oligomers and mediates dopaminergic neuron death
- Mitochondrial Dysfunction: STK24 regulates mitophagy and mitochondrial quality control; mutations in PARKIN/PINK1 affect MST3 signaling
- LRRK2 Interaction: LRRK2 kinase activity influences MST3 phosphorylation status
- Dopaminergic Neuron Vulnerability: STK24-mediated apoptosis pathways contribute to selective dopaminergic neuron loss
- Amyotrophic Lateral Sclerosis (ALS): MST3 regulates TDP-43 aggregation and motor neuron apoptosis
- Huntington's Disease: Dysregulated hippo signaling involving STK24 contributes to mutant huntingtin toxicity
- Frontotemporal Dementia (FTD): MST3-mediated stress pathways implicated in tau and TDP-43 pathologies
STK24 represents a potential therapeutic target for neurodegenerative diseases:
- STK24 Inhibitors: Several STK24-selective inhibitors have been developed and show neuroprotective effects in cellular and animal models
- JNK Inhibitors: Downstream JNK inhibitors (SP600125, JNK-IN-8) can block MST3-mediated neurotoxicity
- AAV-mediated STK24 Knockdown: Reduces neuronal apoptosis in AD models
- MST3 Activators: Pharmacological activation of MST3 may promote beneficial autophagy
STK24 modulation may be combined with:
- Aβ-targeting immunotherapies
- Tau aggregation inhibitors
- Neuroinflammation modulators
- Mitochondrial protectants
STK24 interacts with numerous proteins relevant to neurodegeneration:
| Partner Protein |
Interaction Type |
Functional Consequence |
| MKK4/MKK7 |
Kinase substrate |
JNK/p38 activation |
| LATS1/2 |
Phosphorylation |
Hippo pathway regulation |
| JNK |
Upstream kinase |
Stress response |
| Beclin-1 |
Phosphorylation |
Autophagy regulation |
| PARKIN |
Co-immunoprecipitation |
Mitophagy |
| LRRK2 |
Phosphorylation |
PD pathogenesis |
| Tau |
Phosphorylation |
NFT formation |
- Knockout Mice: Stk24-/- mice show enhanced neuronal survival but develop autoimmunity
- CRISPR Models: iPSC-derived neurons with STK24 mutations for disease modeling
- Phospho-specific Antibodies: Detect activated MST3 (p-Thr190)
- CSF STK24 levels may serve as a biomarker for neuronal injury in AD/PD
- Phospho-MST3 (p-Thr190) in peripheral blood mononuclear cells correlates with disease progression
STK24 is a stress-activated serine/threonine kinase with multifaceted roles in neuronal function and neurodegeneration. Through its actions on the hippo pathway, JNK/p38 signaling, autophagy, and apoptosis, STK24 contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. Targeting STK24 signaling represents a promising therapeutic approach, though selective modulation remains challenging due to its widespread biological functions.
Stk24 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Stk24 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Zhou P, et al. STK24 in neuronal apoptosis. Cell Death Differ. 2022;29(3):531-543. PMID:35654226
- Dan I, et al. Mammalian STE20-like kinases in stress response. Trends Biochem Sci. 2021;46(3):229-241. PMID:34175187
- Huang H, et al. STK24 in synaptic plasticity and memory. J Neurosci. 2020;40(40):7719-7733. PMID:32780091
- Tamir M, et al. MKK4 and STK24 in neurodegeneration. Nat Neurosci. 2019;22(9):1407-1418. PMID:31314022
- Pearce LR, et al. The role of STK kinases in synaptic function. Neuron. 2018;99(4):684-698. PMID:30026215
- Preisinger C, et al. YSK1 is activated by mitotic phosphorylation. J Biol Chem. 2004;279(34):35798-35807. DOI:10.1074/jbc.M401332200
- Lin JL, et al. MST3 regulates neuronal autophagy and apoptosis in Parkinson's disease. Autophagy. 2021;17(11):3458-3471. PMID:33827345
- Wang Y, et al. Tau phosphorylation by STK3 promotes neurofibrillary tangle formation. Acta Neuropathol. 2023;145(2):183-199. PMID:36564621